In this survey, we examined the associated complications and conditions of the patients suffering with Beta Thalassemia major. We focused on major factors which can be helpful to critically understand, diagnose and treat this hematological disorder. This study was conducted at Al-Mustafa Medical Centre, Karachi, Pakistan, from September 2017 to March 2018. A questionnaire was prepared to collect the data and questions were directly asked either from the patient and/or their attendants. Majority of the patients were the part of our survey range between the ages of 1 to 20 years. All the age groups showed the associated complications and different abnormal body conditions. From the total 152 patients, 81 were males and 71 were females. In all...
ABSTRACT Aims: Thalassemia is an inherited hemoglobin disorder caused by anomalies in the globin ch...
Background: Thalassemia major is amongst the most common genetic disorders in developing countries l...
Introduction In Pakistan, the reported carrier rate of thalassaemia is estimated to be 5%–8% with 50...
OBJECTIVES: Despite the correct application of blood transfusions and chelation treatments, beta ...
Disease-related complications and management are different among patients with thalassemia. This stu...
Thalassaemia caused by defects in the synthesis of the haemoglobinchains. Mainly two types of thalas...
Thalassemia syndromes are a heterogeneous group of disorders caused by inherited mutations that decr...
Disease-related complications and management are different among patients with thalassemia. This stu...
The objectives of this study were to determine the impact of Thalassemia \ud major on patients' fami...
Objective:Beta thalassemia major is a prevalent hereditary disease in Mediterranean region especiall...
Beta-thalassemia major (TM) remains to be one of the major health problems particularly in developi...
Thalassemias are hemoglobinopathies and are hereditary deseases which are characterized by disturban...
Abstract. Treatment of thalassemia major is complex, expensive and requires a multidisciplinary appr...
Thalassemia syndromes are among the most serious and common genetic conditions. They are indigenous ...
Introduction: one of long-term complications of Beta-thalassemia major (β-TM) disease is metabolic s...
ABSTRACT Aims: Thalassemia is an inherited hemoglobin disorder caused by anomalies in the globin ch...
Background: Thalassemia major is amongst the most common genetic disorders in developing countries l...
Introduction In Pakistan, the reported carrier rate of thalassaemia is estimated to be 5%–8% with 50...
OBJECTIVES: Despite the correct application of blood transfusions and chelation treatments, beta ...
Disease-related complications and management are different among patients with thalassemia. This stu...
Thalassaemia caused by defects in the synthesis of the haemoglobinchains. Mainly two types of thalas...
Thalassemia syndromes are a heterogeneous group of disorders caused by inherited mutations that decr...
Disease-related complications and management are different among patients with thalassemia. This stu...
The objectives of this study were to determine the impact of Thalassemia \ud major on patients' fami...
Objective:Beta thalassemia major is a prevalent hereditary disease in Mediterranean region especiall...
Beta-thalassemia major (TM) remains to be one of the major health problems particularly in developi...
Thalassemias are hemoglobinopathies and are hereditary deseases which are characterized by disturban...
Abstract. Treatment of thalassemia major is complex, expensive and requires a multidisciplinary appr...
Thalassemia syndromes are among the most serious and common genetic conditions. They are indigenous ...
Introduction: one of long-term complications of Beta-thalassemia major (β-TM) disease is metabolic s...
ABSTRACT Aims: Thalassemia is an inherited hemoglobin disorder caused by anomalies in the globin ch...
Background: Thalassemia major is amongst the most common genetic disorders in developing countries l...
Introduction In Pakistan, the reported carrier rate of thalassaemia is estimated to be 5%–8% with 50...